EP0570414 - NAPHTHOQUINONE DERIVATIVES FOR THE TREATMENT OF CHRONIC INFLAMMATION [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 05.05.2001 Database last updated on 19.10.2024 | Most recent event Tooltip | 05.05.2001 | No opposition filed within time limit | published on 20.06.2001 [2001/25] | Applicant(s) | For all designated states KS BIOMEDIX LTD. 42-46 High Street Esher, Surrey KT10 9QY / GB | [2000/27] |
Former [1999/38] | For all designated states KS BIOMEDIX LTD. 42-46 High Street 78 Hatton Garden Esher, Surrey KT10 9QY / GB | ||
Former [1997/26] | For all designated states KS BIOMEDIX LTD. 32a, High Street Esher, Surrey KT10 9RT / GB | ||
Former [1996/41] | For all designated states CHAYEN, Joseph 38 Sheen Park Richmond, Surrey TW9 1UW / GB | ||
For all designated states BITENSKY, Lucille 38 Sheen Park Richmond, Surrey TW9 1UW / GB | |||
For all designated states FROST, Roberta Elizabeth May 5 Burnthill Road Farnham, Surrey GU10 4RU / GB | |||
Former [1993/47] | For all designated states CHAYEN, Joseph 38 Sheen Park Richmond, Surrey TW9 1UW / GB | ||
For all designated states BITENSKY, Lucille 38 Sheen Park Richmond, Surrey TW9 1UW / GB | |||
For all designated states FROST, George, Thomas, Baxter 5 Burnt Hill Road Farnham, Surrey GU10 4RU / GB | Inventor(s) | 01 /
Chayen, Joseph 38 Sheen Park Richmond, Surrey TW9 1UW / GB | 02 /
Bitensky, Lucille 38 Sheen Park Richmond, Surrey TW9 1UW / GB | 03 /
Frost, George Thomas Baxter deceased / GB | [1996/41] |
Former [1993/47] | 01 /
see applicant ... | Representative(s) | Perry, Robert Edward, et al Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB | [N/P] |
Former [1997/26] | Perry, Robert Edward, et al GILL JENNINGS & EVERY Broadgate House 7 Eldon Street London EC2M 7LH / GB | ||
Former [1993/47] | Perry, Robert Edward GILL JENNINGS & EVERY Broadgate House 7 Eldon Street London EC2M 7LH / GB | Application number, filing date | 92903652.3 | 03.02.1992 | [1993/47] | WO1992GB00196 | Priority number, date | GB19910002340 | 04.02.1991 Original published format: GB 9102340 | GB19910024541 | 19.11.1991 Original published format: GB 9124541 | [1993/47] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO9213532 | Date: | 20.08.1992 | [1992/22] | Type: | A1 Application with search report | No.: | EP0570414 | Date: | 24.11.1993 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.08.1992 takes the place of the publication of the European patent application. | [1993/47] | Type: | B1 Patent specification | No.: | EP0570414 | Date: | 05.07.2000 | Language: | EN | [2000/27] | Search report(s) | International search report - published on: | EP | 29.10.1992 | Classification | IPC: | A61K31/365, A61K31/39, A61K31/12 | [1993/47] | CPC: |
A61K31/7048 (EP,US);
A61K31/12 (EP,US);
A61K31/122 (EP,US);
A61K31/185 (EP,US);
A61K31/336 (EP,US);
A61K31/365 (EP,US);
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, MC, NL, SE [1993/47] | Title | German: | Naphtochinonderivate zur Behandlung von chronischen Entzündungen | [1999/35] | English: | NAPHTHOQUINONE DERIVATIVES FOR THE TREATMENT OF CHRONIC INFLAMMATION | [1993/47] | French: | DERIVES DE NAPHTOQUINONE UTILISES POUR TRAITER LES INFLAMMATIONS CHRONIQUES | [1993/47] |
Former [1993/47] | Maphtochinon Derivative zur Behandlung von chronischen Entzündungen | Entry into regional phase | 27.08.1993 | National basic fee paid | 27.08.1993 | Designation fee(s) paid | 27.08.1993 | Examination fee paid | Examination procedure | 14.02.1992 | Loss of particular rights, legal effect: Claims | 21.08.1992 | Request for preliminary examination filed International Preliminary Examining Authority: DE | 27.08.1993 | Examination requested [1993/47] | 21.01.1994 | Despatch of communication of loss of particular rights: Claims {1} | 05.06.1997 | Despatch of a communication from the examining division (Time limit: M04) | 06.10.1997 | Reply to a communication from the examining division | 21.11.1997 | Despatch of a communication from the examining division (Time limit: M06) | 22.05.1998 | Reply to a communication from the examining division | 31.07.1998 | Despatch of a communication from the examining division (Time limit: M04) | 01.12.1998 | Reply to a communication from the examining division | 11.03.1999 | Despatch of a communication from the examining division (Time limit: M04) | 07.07.1999 | Reply to a communication from the examining division | 31.08.1999 | Despatch of communication of intention to grant (Approval: Yes) | 11.01.2000 | Communication of intention to grant the patent | 13.03.2000 | Fee for grant paid | 13.03.2000 | Fee for publishing/printing paid | Opposition(s) | 06.04.2001 | No opposition filed within time limit [2001/25] | Fees paid | Renewal fee | 08.02.1994 | Renewal fee patent year 03 | 10.02.1995 | Renewal fee patent year 04 | 08.02.1996 | Renewal fee patent year 05 | 10.02.1997 | Renewal fee patent year 06 | 11.02.1998 | Renewal fee patent year 07 | 10.02.1999 | Renewal fee patent year 08 | 11.02.2000 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]EP0147778 (TROPONWERKE GMBH & CO KG [DE]) | [A] - Agents & Actions, volume 12, no. 4, 1982, Birkhauser Verlag, Basel, CH; J. Chayen: "Editorial concerning the possibility of redox drugs", pages 530-535 (cited in the application) | [A] - The Journal of Rheumatology, volume 11, no. 5, October 1984; F. Huck et al.: "Reducing property of some slow acting antirheumatic drugs", pages 605-609 |